Cited by 332Genetic Neurodegenerative DiseasesRNA Research and SplicingMuscle Physiology and Disorders

The DOI matches its Crossref record; 64 of the 65 references it cites were found in a registry or an index.

Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy

Open access

Du, Hongqing, Cline, Melissa S, Osborne, Robert J, Tuttle, Daniel L, Clark, Tyson A, Donohue, John Paul, Hall, Megan P, Shiue, Lily, Swanson, Maurice S, Thornton, Charles A, Ares, Manuel·2010·Nature Structural & Molecular Biology

DOI 10.1038/nsmb.1720PMC PMC2852634

Open this paper in CoChat — free account

Abstract

The common form of myotonic dystrophy (DM1) is associated with the expression of expanded CTG DNA repeats as RNA (CUG(exp) RNA). To test whether CUG(exp) RNA creates a global splicing defect, we compared the skeletal muscle of two mouse models of DM1, one expressing a CTG(exp) transgene and another homozygous for a defective muscleblind 1 (Mbnl1) gene. Strong correlation in splicing changes for approximately 100 new Mbnl1-regulated exons indicates that loss of Mbnl1 explains >80% of the splicing pathology due to CUG(exp) RNA. In contrast, only about half of mRNA-level changes can be attributed to loss of Mbnl1, indicating that CUG(exp) RNA has Mbnl1-independent effects, particularly on mRNAs for extracellular matrix proteins. We propose that CUG(exp) RNA causes two separate effects: loss of Mbnl1 function (disrupting splicing) and loss of another function that disrupts extracellular matrix mRNA regulation, possibly mediated by Mbnl2. These findings reveal unanticipated similarities between DM1 and other muscular dystrophies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nsmb.1720

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
In silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F. Z., Miled, S. B., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,785
Significance analysis of microarrays applied to the ionizing radiation response
Tusher, V. G., Tibshirani, R., & Chu, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091062498 · Cited by 10,568
Recruitment of human muscleblind proteins to (CUG)n expansions associated with myotonic dystrophy
Miller, J. W., Urbinati, C. R., Teng‐umnuay, P., Stenberg, M. G., Byrne, B. J., Thornton, C. A., & Swanson, M. S. (2000) · The EMBO Journal · doi:10.1093/emboj/19.17.4439 · Cited by 937
Self-citation
Expandable DNA repeats and human disease
Mirkin, S. M. (2007) · Nature · doi:10.1038/nature05977 · Cited by 934
Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy
Savkur, R. S., Philips, A. V., & Cooper, T. A. (2001) · Nature Genetics · doi:10.1038/ng704 · Cited by 795
A Muscleblind Knockout Model for Myotonic Dystrophy
Kanadia, R. N., Johnstone, K. A., Mankodi, A., Lungu, C., Thornton, C. A., Esson, D., Timmers, A. M., Hauswirth, W. W., & Swanson, M. S. (2003) · Science · doi:10.1126/science.1088583 · Cited by 743
Self-citation
Myotonic Dystrophy in Transgenic Mice Expressing an Expanded CUG Repeat
Mankodi, A. K., Logigian, E. L., Callahan, L. M., McClain, C., White, R. J., Henderson, D., Krym, M., & Thornton, C. A. (2000) · Science · doi:10.1126/science.289.5485.1769 · Cited by 738
Self-citation
Expanded CUG Repeats Trigger Aberrant Splicing of ClC-1 Chloride Channel Pre-mRNA and Hyperexcitability of Skeletal Muscle in Myotonic Dystrophy
Mankodi, A. K., Takahashi, M. P., Jiang, H. N., Beck, C. L., Bowers, W. J., Moxley, R. T., Cannon, S. C., & Thornton, C. A. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00563-4 · Cited by 672
Self-citation
Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy
Buxton, J. L., Shelbourne, P., Davies, J. L., Jones, C., Tongeren, T. V., Aslanidis, C., de Jong, P., Jansen, G., Anvret, M., Riley, B. P., et al. (1992) · Nature · doi:10.1038/355547a0 · Cited by 623

Show all 65 references

Sorted by citations

Items 101–200 of 331

The Role of Polypyrimidine Tract-Binding Proteins and Other hnRNP Proteins in Plant Splicing Regulation
Wachter, A., Rühl, C., & Stauffer, E. (2012) · Frontiers in Plant Science · doi:10.3389/fpls.2012.00081 · Cited by 54
Altered MEF2 isoforms in myotonic dystrophy and other neuromuscular disorders
Bachinski, L. L., Sirito, M., Böhme, M., Baggerly, K., Udd, B., & Krahe, R. (2010) · Muscle & Nerve · doi:10.1002/mus.21789 · Cited by 54
Therapeutics development in myotonic dystrophy type 1
Foff, E. P., & Mahadevan, M. S. (2011) · Muscle & Nerve · doi:10.1002/mus.22090 · Cited by 52
Muscleblind-like 1 (Mbnl1) regulates pre-mRNA alternative splicing during terminal erythropoiesis
Cheng, A. W., Shi, J., Wong, P., Luo, K. L., Trepman, P. C., Wang, E. T., Choi, H., Burge, C. B., & Lodish, H. F. (2014) · Blood · doi:10.1182/blood-2013-12-542209 · Cited by 51
Identification of MBNL1 and MBNL3 domains required for splicing activation and repression
Grammatikakis, I., Goo, Y., Echeverria, G. V., & Cooper, T. A. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq1155 · Cited by 51
Antisense Oligonucleotides: Rising Stars in Eliminating RNA Toxicity in Myotonic Dystrophy
Gao, Z., & Cooper, T. A. (2012) · Human Gene Therapy · doi:10.1089/hum.2012.212 · Cited by 51
The many functions of mRNA localization during normal development and disease: from pillar to post
Cody, N. A. L., Iampietro, C., & Lécuyer, É. (2013) · Wiley Interdisciplinary Reviews Developmental Biology · doi:10.1002/wdev.113 · Cited by 51
Alternative splicing regulation by Muscleblind proteins: from development to disease
Fernández‐Costa, J. M., Llamusí, B., García-López, A., & Artero, R. D. (2011) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/j.1469-185x.2011.00180.x · Cited by 54
Ubiquitination of MBNL1 Is Required for Its Cytoplasmic Localization and Function in Promoting Neurite Outgrowth
Wang, P.-Y., Chang, K., Lin, Y.-M., Kuo, T., & Wang, G. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.02.025 · Cited by 51
HNRNPA1-induced spliceopathy in a transgenic mouse model of myotonic dystrophy
Li, M., Zhuang, Y., Batra, R., Thomas, J. D., Mao, L., Nutter, C. A., Scotti, M. M., Carter, H. A., Wang, Z. J., Huang, X., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1907297117 · Cited by 51
Self-citation
DDX6 regulates sequestered nuclear CUG-expanded DMPK-mRNA in dystrophia myotonica type 1
Pettersson, O. J., Aagaard, L., Andrējeva, D., Thomsen, R., Jensen, T. G., & Damgaard, C. K. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku352 · Cited by 49
Phenylbutazone induces expression of MBNL1 and suppresses formation of MBNL1-CUG RNA foci in a mouse model of myotonic dystrophy
Chen, G., Masuda, A., Konishi, H., Ohkawara, B., Ito, M., Kinoshita, M., Kiyama, H., Matsuura, T., & Ohno, K. (2016) · Scientific Reports · doi:10.1038/srep25317 · Cited by 49
Increased Muscleblind levels by chloroquine treatment improve myotonic dystrophy type 1 phenotypes in in vitro and in vivo models
Bargiela, A., Sabater-Arcis, M., Espinosa-Espinosa, J., Zulaica, M., de Munaín, A. L., & Artero, R. D. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1820297116 · Cited by 56
Muscleblind-like 1 activates insulin receptor exon 11 inclusion by enhancing U2AF65 binding and splicing of the upstream intron
Echeverria, G. V., & Cooper, T. A. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1020 · Cited by 50
Autoregulation of MBNL1 function by exon 1 exclusion from MBNL1 transcript
Konieczny, P., Stępniak-Konieczna, E., Taylor, K., Sznajder, Ł. J., & Sobczak, K. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw1158 · Cited by 48
Gain of RNA function in pathological cases: Focus on myotonic dystrophy
Klein, A. F., Gasnier, E., & Furling, D. (2011) · Biochimie · doi:10.1016/j.biochi.2011.06.028 · Cited by 50
Targeted splice sequencing reveals RNA toxicity and therapeutic response in myotonic dystrophy
Tanner, M. K., Tang, Z., & Thornton, C. A. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab022 · Cited by 46
Self-citation
MBNL1 and PTB cooperate to repress splicing of Tpm1 exon 3
Gooding, C., Edge, C., Lorenz, M., Coelho, M. B., Winters, M. U., Kaminski, C. F., Cherny, D., Eperon, I. C., & Smith, C. W. J. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt168 · Cited by 45
Oxidative stress in muscular dystrophy: from generic evidence to specific sources and targets
Canton, M., Menazza, S., & Lisa, F. D. (2014) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-014-9380-2 · Cited by 49
Staufen1 Regulates Multiple Alternative Splicing Events either Positively or Negatively in DM1 Indicating Its Role as a Disease Modifier
Bondy‐Chorney, E., Parks, T. E. C., Ravel‐Chapuis, A., Klinck, R., Rocheleau, L., Pelchat, M., Chabot, B., Jasmin, B. J., & Côté, J. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1005827 · Cited by 49
Derepressing muscleblind expression by miRNA sponges ameliorates myotonic dystrophy-like phenotypes in Drosophila
Cerro-Herreros, E., Fernández‐Costa, J. M., Sabater-Arcis, M., Llamusí, B., & Artero, R. D. (2016) · Scientific Reports · doi:10.1038/srep36230 · Cited by 45
Of Mice and Men: Advances in the Understanding of Neuromuscular Aspects of Myotonic Dystrophy
Bráz, S., Acquaire, J., Gourdon, G., & Gomes-Pereira, M. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00519 · Cited by 45
Integration of a splicing regulatory network within the meiotic gene expression program of Saccharomyces cerevisiaePreprint
Munding, E. M., Igel, A. H., Shiue, L., Dorighi, K. M., Treviño, L. R., & Ares, M. (2010) · Genes & Development · doi:10.1101/gad.1977410 · Cited by 47
Self-citation
Muscleblind, BSF and TBPH are mislocalized in the muscle sarcomere of aDrosophilamyotonic dystrophy model
Llamusí, B., Bargiela, A., Fernández‐Costa, J. M., García-López, A., Klima, R., Feiguin, F. M., & Artero, R. D. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.009563 · Cited by 44
Dysregulation of Circular RNAs in Myotonic Dystrophy Type 1
Voellenkle, C., Perfetti, A., Carrara, M., Fuschi, P., Renna, L. V., Longo, M., Sain, S. B., Cardani, R., Valaperta, R., Silvestri, G., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081938 · Cited by 48
The four Zn fingers of MBNL1 provide a flexible platform for recognition of its RNA binding elements
Cass, D. M., Hotchko, R., Barber, P., Jones, K., Gates, D. P., & Berglund, J. A. (2011) · BMC Molecular Biology · doi:10.1186/1471-2199-12-20 · Cited by 44
Activation of the innate immune response and interferon signalling in myotonic dystrophy type 1 and type 2 cataracts
Rhodes, J. D., Lott, M. C., Russell, S., Moulton, V., Sanderson, J., Wormstone, I. M., & Broadway, D. C. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr515 · Cited by 47
Repeat-Associated Non-AUG Translation and Its Impact in Neurodegenerative Disease
Kearse, M. G., & Todd, P. K. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0292-z · Cited by 43
Native functions of short tandem repeats
Wright, S. E., & Todd, P. K. (2023) · eLife · doi:10.7554/elife.84043 · Cited by 44
RNA Degradation in Neurodegenerative Disease
Weskamp, K., & Barmada, S. J. (2018) · Advances in neurobiology · doi:10.1007/978-3-319-89689-2_5 · Cited by 41
MBNL splicing activity depends on RNA binding site structural context
Taylor, K., Sznajder, Ł. J., Cywoniuk, P., Thomas, J. D., Swanson, M. S., & Sobczak, K. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky565 · Cited by 42
Self-citation
Alternative splicing of myomesin 1 gene is aberrantly regulated in myotonic dystrophy type 1
Koebis, M., Ohsawa, N., Kino, Y., Sasagawa, N., Nishino, I., & Ishiura, S. (2011) · Genes to Cells · doi:10.1111/j.1365-2443.2011.01542.x · Cited by 41
Treatment of Type 1 Myotonic Dystrophy by Engineering Site-specific RNA Endonucleases that Target (CUG)n Repeats
Zhang, W., Wang, Y., Dong, S., Choudhury, R., Jin, Y., & Wang, Z. (2013) · Molecular Therapy · doi:10.1038/mt.2013.251 · Cited by 41
Myotonic Dystrophy and Developmental Regulation of RNA Processing
Thomas, J. D., Oliveira, R., Sznajder, Ł. J., & Swanson, M. S. (2018) · Comprehensive physiology · doi:10.1002/cphy.c170002 · Cited by 51
Self-citation
RNA Splicing Is Responsive to MBNL1 Dose
Jog, S. P., Paul, S., Dansithong, W., Tring, S., Comai, L., & Reddy, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048825 · Cited by 40
MBNL1–RNA Recognition: Contributions of MBNL1 Sequence and RNA Conformation
Fu, Y., Ramisetty, S. R., Hussain, N., & Baranger, A. M. (2011) · ChemBioChem · doi:10.1002/cbic.201100487 · Cited by 39
Novel Drosophila model of myotonic dystrophy type 1: phenotypic characterization and genome-wide view of altered gene expression
Picchio, L., Auxerre-Plantié, E., Renaud, Y., Poovathumkadavil, P., & Jagla, K. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt127 · Cited by 40
Cancer phenotype in myotonic dystrophy patients: Results from a meta‐analysis
Emparanza, J. I., de Munaín, A. L., Greene, M. H., Matheu, A., Fernández‐Torrón, R., & Gadalla, S. M. (2018) · Muscle & Nerve · doi:10.1002/mus.26194 · Cited by 40
Molecular therapy in myotonic dystrophy: focus on RNA gain-of-function
Mulders, S. A. M., van Engelen, B. G. M., Wieringa, B., & Wansink, D. G. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq161 · Cited by 45
A flow cytometry-based screen identifies MBNL1 modulators that rescue splicing defects in myotonic dystrophy type I
Zhang, F., Bodycombe, N. E., Haskell, K., Sun, Y., Wang, E. T., Morris, C. A., Jones, L. H., Wood, L. D., & Pletcher, M. T. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx190 · Cited by 40
Utilizing the GAAA Tetraloop/Receptor To Facilitate Crystal Packing and Determination of the Structure of a CUG RNA Helix
Coonrod, L. A., Lohman, J. R., & Berglund, J. A. (2012) · Biochemistry · doi:10.1021/bi300829w · Cited by 39
Global Increase in Circular RNA Levels in Myotonic Dystrophy
Czubak, K., Taylor, K., Piasecka, A., Sobczak, K., Kozlowska, K., Philips, A., Sedehizadeh, S., Brook, J. D., Wojciechowska, M., & Kozłowski, P. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00649 · Cited by 41
Myoediting: Toward Prevention of Muscular Dystrophy by Therapeutic Genome Editing
Zhang, Y., Long, C., Bassel‐Duby, R., & Olson, E. N. (2018) · Physiological Reviews · doi:10.1152/physrev.00046.2017 · Cited by 42
Transcriptional changes and developmental abnormalities in a zebrafish model of myotonic dystrophy type 1
Todd, P. K., Ackall, F. Y., Hur, J., Sharma, K., Paulson, H. L., & Dowling, J. J. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.012427 · Cited by 37
Furamidine Rescues Myotonic Dystrophy Type I Associated Mis-Splicing through Multiple Mechanisms
Jenquin, J. R., Coonrod, L. A., Silverglate, Q., Pellitier, N. A., Hale, M. A., Xia, G., Nakamori, M., & Berglund, J. A. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.8b00646 · Cited by 38
Bioengineered in vitro 3D model of myotonic dystrophy type 1 human skeletal muscle
Fernández‐Garibay, X., Ortega, M. A., Cerro-Herreros, E., Comelles, J., Martínez, E., Artero, R. D., Fernández‐Costa, J. M., & Ramón‐Azcón, J. (2021) · Biofabrication · doi:10.1088/1758-5090/abf6ae · Cited by 38
Reduced cytoplasmic MBNL1 is an early event in a brain-specific mouse model of myotonic dystrophy
Wang, P.-Y., Lin, Y.-M., Wang, L., Kuo, T., Cheng, S., & Wang, G. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx115 · Cited by 37
RBM25/LUC7L3 Function in Cardiac Sodium Channel Splicing Regulation of Human Heart Failure
Gao, G., & Dudley, S. C. (2012) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2012.08.003 · Cited by 36
Caenorhabditis elegans Muscleblind homolog mbl-1 functions in neurons to regulate synapse formation
Spilker, K. A., Wang, G. J., Tugizova, M. S., & Shen, K. (2012) · Neural Development · doi:10.1186/1749-8104-7-7 · Cited by 36
Epigenetic changes and non-coding expanded repeats
Nakamori, M., & Thornton, C. A. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.02.004 · Cited by 36
Self-citation
Misregulation of calcium-handling proteins promotes hyperactivation of calcineurin–NFAT signaling in skeletal muscle of DM1 mice
Ravel‐Chapuis, A., Bélanger, G., Côté, J., Michel, R. N., & Jasmin, B. J. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx109 · Cited by 35
Most expression and splicing changes in myotonic dystrophy type 1 and type 2 skeletal muscle are shared with other muscular dystrophies
Bachinski, L. L., Baggerly, K., Neubauer, V. L., Nixon, T. J., Raheem, O., Sirito, M., Unruh, A. K., Zhang, J., Nagarajan, L., Timchenko, L., et al. (2013) · Neuromuscular Disorders · doi:10.1016/j.nmd.2013.11.001 · Cited by 34
Cancer Risk in Myotonic Dystrophy Type I: Evidence of a Role for Disease Severity
Alsaggaf, R., George, D. M. M. S., Zhan, M., Pfeiffer, R. M., Wang, Y., Wagner, K. R., Greene, M. H., Amr, S., & Gadalla, S. M. (2018) · JNCI Cancer Spectrum · doi:10.1093/jncics/pky052 · Cited by 36
RNA-Binding Protein Misregulation in Microsatellite Expansion Disorders
Goodwin, M., & Swanson, M. S. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-1221-6_10 · Cited by 33
Self-citation
Repeat-associated RNA structure and aberrant splicing
Hale, M. A., Johnson, N. E., & Berglund, J. A. (2019) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2019.07.006 · Cited by 35
MBNL142 and MBNL143 gene isoforms, overexpressed in DM1-patient muscle, encode for nuclear proteins interacting with Src family kinases
Botta, A., Malena, A., Tibaldi, E. V., Rocchi, L., Loro, E., Pena, E., Cenci, L., Ambrosi, E., Bellocchi, M. C., Pagano, M. A., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.291 · Cited by 33
Combination Treatment of Erythromycin and Furamidine Provides Additive and Synergistic Rescue of Mis-splicing in Myotonic Dystrophy Type 1 Models
Jenquin, J. R., Yang, H., Huigens, R. W., Nakamori, M., & Berglund, J. A. (2019) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.9b00020 · Cited by 33
Evaluating the effects of CELF1 deficiency in a mouse model of RNA toxicity
Kim, Y. K., Mandal, M., Yadava, R. S., Paillard, L., & Mahadevan, M. S. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt419 · Cited by 33
Design of Bivalent Nucleic Acid Ligands for Recognition of RNA-Repeated Expansion Associated with Huntington’s Disease
Thadke, S. A., Perera, J. D. R., Hridya, V. M., Bhatt, K. S., Shaikh, A. Y., Hsieh, W., Chen, M., Gayathri, C., Gil, R. R., Rule, G. S., et al. (2018) · Biochemistry · doi:10.1021/acs.biochem.8b00062 · Cited by 33
Self-citation
Modifications to toxic CUG RNAs induce structural stability, rescue mis-splicing in a myotonic dystrophy cell model and reduce toxicity in a myotonic dystrophy zebrafish model
deLorimier, E., Coonrod, L. A., Copperman, J., Taber, A. M., Reister, E., Sharma, K., Todd, P. K., Guenza, M., & Berglund, J. A. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku941 · Cited by 32
Alternative Splicing of Transcription Factors Genes in Muscle Physiology and Pathology
Imbriano, C., & Molinari, S. (2018) · Genes · doi:10.3390/genes9020107 · Cited by 35
CRISPR gene editing in pluripotent stem cells reveals the function of MBNL proteins during humanin vitromyogenesis
Mérien, A., Tahraoui‐Bories, J., Cailleret, M., Dupont, J.-B., Leteur, C., Polentes, J., Carteron, A., Polvèche, H., Concordet, J., Pinset, C., et al. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab218 · Cited by 33
Bidirectional transcription of trinucleotide repeats: Roles for excision repair
Budworth, H., & McMurray, C. T. (2013) · DNA repair · doi:10.1016/j.dnarep.2013.04.019 · Cited by 34
Smaug/SAMD4A Restores Translational Activity of CUGBP1 and Suppresses CUG-Induced Myopathy
de Haro, M., Al‐Ramahi, I., Jones, K. R., Holth, J. K., Timchenko, L., & Botas, J. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003445 · Cited by 31
Altered expression and splicing of Ca2+ metabolism genes in myotonic dystrophies DM1 and DM2
Vihola, A., Sirito, M., Bachinski, L. L., Raheem, O., Screen, M., Suominen, T., Krahe, R., & Udd, B. (2012) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2012.01289.x · Cited by 30
Identification of genes in toxicity pathways of trinucleotide-repeat RNA in C. elegans
Garcia, S. M. D. A., Tabach, Y., Lourenco, G. F., Armakola, M., & Ruvkun, G. (2014) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2858 · Cited by 29
Quantifying Cancer Absolute Risk and Cancer Mortality in the Presence of Competing Events after a Myotonic Dystrophy Diagnosis
Gadalla, S. M., Pfeiffer, R. M., Kristinsson, S. Y., Björkholm, M., Hilbert, J. E., Moxley, R. T., Landgren, O., & Greene, M. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079851 · Cited by 29
The potential of engineered eukaryotic RNA‐binding proteins as molecular tools and therapeutics
Shotwell, C. R., Cleary, J. D., & Berglund, J. A. (2019) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1573 · Cited by 25
The Splice Index as a prognostic biomarker of strength and function in myotonic dystrophy type 1
Provenzano, M., Ikegami, K., Bates, K., Gaynor, A., Hartman, J. M., Jones, A. S., Butler, A., Berggren, K. N., Dekdebrun, J. M., Hung, M., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci185426 · Cited by 27
Self-citation
Non-invasive monitoring of alternative splicing outcomes to identify candidate therapies for myotonic dystrophy type 1
Hu, N., Antoury, L., Baran, T. M., Mitra, S., Bennett, C. F., Rigo, F., Foster, T. H., & Wheeler, T. M. (2018) · Nature Communications · doi:10.1038/s41467-018-07517-y · Cited by 27
Combinatorial Mutagenesis of MBNL1 Zinc Fingers Elucidates Distinct Classes of Regulatory Events
Purcell, J., Oddo, J. C., Wang, E. T., & Berglund, J. A. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00274-12 · Cited by 29
Myoblasts generated by lentiviral mediated MyoD transduction of myotonic dystrophy type 1 (DM1) fibroblasts can be used for assays of therapeutic molecules
Larsen, J., Pettersson, O. J., Jakobsen, M., Thomsen, R., Pedersen, C. B., Hertz, J. M., Gregersen, N., Corydon, T. J., & Jensen, T. G. (2011) · BMC Research Notes · doi:10.1186/1756-0500-4-490 · Cited by 26
Regulation of splicing and circularisation of RNA in epithelial mesenchymal plasticity
Neumann, D., Goodall, G. J., & Gregory, P. A. (2017) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2017.08.008 · Cited by 25
Dynamics and variability of transcriptomic dysregulation in congenital myotonic dystrophy during pediatric development
Hale, M. A., Bates, K., Provenzano, M., & Johnson, N. E. (2022) · Human Molecular Genetics · doi:10.1093/hmg/ddac254 · Cited by 25
Genome Wide Identification of Aberrant Alternative Splicing Events in Myotonic Dystrophy Type 2
Perfetti, A., Greco, S., Fasanaro, P., Bugiardini, E., Cardani, R., Manteiga, J. M. G., Riba, M., Cittaro, D., Stupka, E., Meola, G., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093983 · Cited by 25
Cells of Matter—In Vitro Models for Myotonic Dystrophy
Matłoka, M., Klein, A. F., Rau, F., & Furling, D. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00361 · Cited by 25
Conserved functions of RNA-binding proteins in muscle
Nikonova, E. V., Kao, S.-Y., Ravichandran, K., Wittner, A., & Spletter, M. L. (2019) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2019.02.008 · Cited by 24
Benign tumors in myotonic dystrophy type I target disease‐related cancer sites
Alsaggaf, R., George, D. M. M. S., Zhan, M., Pfeiffer, R. M., Wang, Y., Anderson, L. A., Liu, Z., Koshiol, J. E., Bauer, A. J., Wagner, K. R., et al. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.50856 · Cited by 25
Fourier-Transform Infrared Spectroscopy as a Discriminatory Tool for Myotonic Dystrophy Type 1 Metabolism: A Pilot Study
Mateus, T., Almeida, I., Costa, A., Viegas, D., Magalhães, S., Martins, F., Herdeiro, M. T., Silva, O. A. B. D. C. E., Fraga, C., Alves, I., et al. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18073800 · Cited by 23
Proof of concept of peptide-linked blockmiR-induced MBNL functional rescue in myotonic dystrophy type 1 mouse model
Overby, S. J., Cerro-Herreros, E., González-Martínez, I., Varela, M. A., Seoane-Miraz, D., Jad, Y. E., Raz, R., Møller, T., Pérez‐Alonso, M., Wood, M. J. A., et al. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.02.003 · Cited by 24
Clinical and Molecular Insights into Gastrointestinal Dysfunction in Myotonic Dystrophy Types 1 & 2
Peterson, J. A. M., & Cooper, T. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314779 · Cited by 24
Myotonic dystrophy
Mahadevan, M. S. (2012) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328357b0d9 · Cited by 24
High-throughput analysis of the RNA-induced silencing complex in myotonic dystrophy type 1 patients identifies the dysregulation of miR-29c and its target ASB2
Cappella, M., Perfetti, A., Cardinali, B., García-Manteiga, J. M., Carrara, M., Provenzano, C., Fuschi, P., Cardani, R., Renna, L. V., Meola, G., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0769-5 · Cited by 23
MBNL1 overexpression is not sufficient to rescue the phenotypes in a mouse model of RNA toxicity
Yadava, R. S., Kim, Y. K., Mandal, M., Mahadevan, K., Gladman, J. T., Yu, Q. C., & Mahadevan, M. S. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz065 · Cited by 24
A CRISPR-Cas13a Based Strategy That Tracks and Degrades Toxic RNA in Myotonic Dystrophy Type 1
Zhang, N., Bewick, B., Xia, G., Furling, D., & Ashizawa, T. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.594576 · Cited by 24
Alternative Pre-mRNA Splicing
Wagner, S. D., & Berglund, J. A. (2014) · Methods in molecular biology · doi:10.1007/978-1-62703-980-2_4 · Cited by 24
Antisense oligonucleotide and adjuvant exercise therapy reverse fatigue in old mice with myotonic dystrophy
Hu, N., Kim, E. J., Antoury, L., Li, J., González-Pérez, P., Rutkove, S. B., & Wheeler, T. M. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.11.014 · Cited by 24
Preclinical characterization of antagomiR-218 as a potential treatment for myotonic dystrophy
Cerro-Herreros, E., González-Martínez, I., Moreno, N., Espinosa-Espinosa, J., Fernández‐Costa, J. M., Colom-Rodrigo, A., Overby, S. J., Seoane-Miraz, D., Poyatos‐García, J., Vilchez, J. J., et al. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.07.017 · Cited by 23
Muscleblind-like 2 controls the hypoxia response of cancer cells
Fischer, S. E., Liddo, A. D., Taylor, K., Gerhardus, J. S., Sobczak, K., Zarnack, K., & Weigand, J. E. (2020) · RNA · doi:10.1261/rna.073353.119 · Cited by 23
Altered nuclear structure in myotonic dystrophy type 1-derived fibroblasts
Rodríguez, R., Hernández‐Hernández, Ó., Magaña, J. J., González‐Ramírez, R., García‐López, E. S., & Cisneros, B. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3791-4 · Cited by 22
Conserved RNA-Binding Proteins Required for Dendrite Morphogenesis inCaenorhabditis elegansSensory Neurons
Antonacci, S., Forand, D., Wolf, M., Tyus, C., Barney, J., Kellogg, L., Simon, M. A., Kerr, G., Wells, K. L., Younes, S., et al. (2015) · G3 Genes Genomes Genetics · doi:10.1534/g3.115.017327 · Cited by 22
Recovery in the Myogenic Program of Congenital Myotonic Dystrophy Myoblasts after Excision of the Expanded (CTG)n Repeat
André, L. M., van Cruchten, R. T. P., Willemse, M. P., Bezstarosti, K., Demmers, J., van Agtmaal, E. L., Wansink, D. G., & Wieringa, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225685 · Cited by 23
RNA-Binding Proteins in Heart Development
Giudice, J., & Cooper, T. A. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-1221-6_11 · Cited by 23
Myotonic dystrophy type 1: clinical diversity, molecular insights and therapeutic perspectives
Rahm, L., Hale, M. A., Raaijmakers, R. H. L., Quiñones, A. M., Patki, T., Johnson, N. E., van Bokhoven, H., & Mul, K. (2025) · Nature Reviews Neurology · doi:10.1038/s41582-025-01139-x · Cited by 24
Metabolic Alterations in Myotonic Dystrophy Type 1 and Their Correlation with Lipin
Mateus, T., Martins, F., Nunes, A., Herdeiro, M. T., & Rebelo, S. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18041794 · Cited by 21
Integrative Cell Type-Specific Multi-Omics Approaches Reveal Impaired Programs of Glial Cell Differentiation in Mouse Culture Models of DM1
González‐Barriga, A., Lallemant, L., Dincã, D. M., Bráz, S., Polvèche, H., Magneron, P., Pionneau, C., Huguet-Lachon, A., Claude, J., Chhuon, C., et al. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.662035 · Cited by 21
Genome-Wide Activities of RNA Binding Proteins That Regulate Cellular Changes in the Epithelial to Mesenchymal Transition (EMT)
Bebee, T. W., Cieply, B. W., & Carstens, R. P. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-1221-6_8 · Cited by 23
Deep brain stimulation modulates nonsense-mediated RNA decay in Parkinson’s patients leukocytes
Soreq, L., Bergman, H., Israel, Z. H., & Soreq, H. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-478 · Cited by 21
Transcriptome Analysis in a Primary Human Muscle Cell Differentiation Model for Myotonic Dystrophy Type 1
Todorow, V., Hintze, S., Kerr, A. R. W., Hehr, A., Schoser, B. G. H., & Meinke, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168607 · Cited by 20
Combinatorial treatment with exercise and AICAR potentiates the rescue of myotonic dystrophy type 1 mouse muscles in a sex-specific manner
Misquitta, N. S., Ravel‐Chapuis, A., & Jasmin, B. J. (2022) · Human Molecular Genetics · doi:10.1093/hmg/ddac222 · Cited by 20

Authors: Du, H., Cline, M. S., Osborne, R. J., Tuttle, D. L., Clark, T. A., Donohue, J. P., Hall, M. P., Shiue, L., Swanson, M. S., Thornton, C. A., & Ares, M.
Affiliations: University of California, Santa Cruz (US)
University of Rochester Medicine (US)
University of Florida (US)
Affymetrix (United States) (US)
Corresponding author: Ares, Manuel
ORCID: Du, Hongqing
Cline, Melissa S
Osborne, Robert J
Clark, Tyson A
Hall, Megan P
Shiue, Lily
Swanson, Maurice S
Thornton, Charles A
Ares, Manuel
Venue: Nature Structural & Molecular Biology
Publisher: Springer Science and Business Media LLC
Published: 2010-01-24
Volume: 17
Issue: 2
Pages: 187-193
ISSN: 1545-9985 (ISSN-L)
1545-9993
DOI: 10.1038/nsmb.1720
PMC: PMC2852634
OpenAlex: W2110459103
Cited by: 332
References: 65
Citations by year: 2026: 11 · 2025: 13 · 2024: 13 · 2023: 9 · 2022: 17 · 2021: 17 · 2020: 10 · 2019: 17 · 2018: 30 · 2017: 17 · 2016: 17 · 2015: 14 · 2014: 34 · 2013: 36 · 2012: 32
FWCI: 14.59
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature Structural & Molecular Biology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health (5u54ns048843-12)
National Institute of General Medical Sciences (R01GM084317, GM040478, R01GM040478, GM084317)
National Institute of Neurological Disorders and Stroke (U54‐NS048843)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR049077, AR046799, K24AR048143, R01AR046799, R01AR046806, AR046806)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
Keywords: myotonic dystrophy type 1, CUG repeat expansion, MBNL1, MBNL2, alternative splicing, extracellular matrix gene expression, RNA-binding proteins, skeletal muscle, gene expression profiling, muscular dystrophy, mouse model
MeSH terms: Animals, Disease Models, Animal, DNA-Binding Proteins, Models, Biological, Myotonic Dystrophy, Repetitive Sequences, Nucleic Acid, RNA, Messenger, Gene Expression, Extracellular Matrix Proteins, RNA-Binding Proteins, Alternative Splicing, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks